In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Financing Deals Strategy

Deerfield Management On Fund Building, Philanthropy, And Optimism For The Future

  • Interviews

Executive Summary

Andrew ElBardissi, partner on Deerfield Management’s medical technologies team, spoke to In Vivo sister publication Medtech Insight about the fund’s investment strategy, the changing face of medtech, and how investment in the life sciences sector will continue to change post-COVID.

You may also be interested in...



Investor Eye: What's Changing In Medtech Deal Making As We Approach The End Of 2022?

Kristen Pothier, global lead of KPMG’s health care and life sciences advisory service, spoke to Medtech Insight about the current deal making climate, and how it impacts the diagnostics sector.

CobiCure Will Develop Cardiac Devices For Children, Sans Profit Motive

CobiCure is pursuing a non-profit approach to the development of cardiac devices for underserved patient populations.

Minute Insight: Maestro Cues The Music With CE Mark For Moon Surgical

The Paris-based start-up has picked up a CE mark for the latest generation of its Maestro system, a tool designed to make laparoscopic surgery easier and safer.

Table

View full table

Topics

Related Companies

Tags:
Financing Deals Strategy
Latest Headlines

Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition

AI Medical Imaging And Radiotherapy First For UK’s NICE

The Power Of AI To Map The Patient Journey

A Next-Gen Approach To Health Care Risk And Compliance

See All
UsernamePublicRestriction

Register

IV146700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By